NPs Basic Information

Name
Umbelliferone
Molecular Formula C9H6O3
IUPAC Name*
7-hydroxychromen-2-one
SMILES
C1=CC(=CC2=C1C=CC(=O)O2)O
InChI
InChI=1S/C9H6O3/c10-7-3-1-6-2-4-9(11)12-8(6)5-7/h1-5,10H
InChIKey
ORHBXUUXSCNDEV-UHFFFAOYSA-N
Synonyms
Umbelliferone; 7-hydroxycoumarin; 93-35-6; 7-Hydroxy-2H-chromen-2-one; Hydrangin; Skimmetin; 7-hydroxycoumarine; Hydrangine; Skimmetine; 7-Oxycoumarin; Umbelliferon; 2H-1-Benzopyran-2-one, 7-hydroxy-; 7-Hydroxy-2H-1-benzopyran-2-one; 7-hydroxychromen-2-one; Coumarin, 7-hydroxy-; beta-Umbelliferone; 7-hydroxy coumarin; NSC 19790; 7 HC; 7-hydroxy-coumarin; MFCD00006878; NSC19790; CHEMBL51628; 60Z60NTL4G; 7-HC; 7-hydroxy-1-benzopyran-2-one; CHEBI:27510; NSC-19790; 7-oxidanylchromen-2-one; 7-hydroxycumarin; Dichrin A; CCRIS 3591; EINECS 202-240-3; 32922-68-2; BRN 0127683; UNII-60Z60NTL4G; AI3-38054; 7-hydroxycoumarin, 14C-labeled; 7-hydroxycournarin; beta -umbelliferone; 07L; 7-hydroxy-coumarine; .beta.-Umbelliferone; Umbelliferone, 99%; 7-Hydroxy-2-chromenone; Coumarin derivative, 3a; 7 OH COUMARIN; Spectrum2_001962; Spectrum3_000751; 7-hydroxy-chromen-2-one; 7-hydroxycoumarin sulphate; UMBELLIFERONE [MI]; 7-Hydroxy Coumarin ,(S); BIDD:PXR0126; SCHEMBL22018; BSPBio_002362; SPECTRUM231084; 5-18-01-00386 (Beilstein Handbook Reference); MLS002207035; BIDD:ER0671; 2-Hydroxy-7H-chromen-7-one; SPBio_002083; 7-Hydroxy Coumarin-[13C6]; UMBELLIFERONE [WHO-DD]; MEGxp0_000814; DTXSID5052626; ACon1_000219; KBio3_001582; ZINC58111; 7-Hydroxy-2H-chromen-2-one #; Umbelliferone, analytical standard; HMS1607M21; HMS2271N09; HMS3741M03; 2-Hydroxy-7H-1-benzopyran-7-one; ALBB-021296; CS-D1186; HY-N0573; STR04824; BBL027620; BDBM50174558; CCG-39436; s3675; STK331042; Umbelliferone (Hydrangin, Skimmetin); AKOS000120867; NSC-019790; SDCCGMLS-0066941.P001; 7-Hydroxycoumarin;Hydrangin;NSC 19790; NCGC00095801-01; NCGC00095801-02; NCGC00095801-03; NCGC00178691-01; NCGC00178691-02; AC-18399; AC-34707; NCI60_001646; SMR000112324; SY001924; DB-014673; BB 0218364; FT-0621430; H0236; EN300-18075; Umbelliferone, Vetec(TM) reagent grade, 98%; A14827; C09315; U-3000; A801734; A844525; Q416196; BRD-K87991767-001-02-0; BRD-K87991767-001-03-8; Z57150899; F0722-0129; 7-Hydroxycoumarin; Umbelliferone; 7-Hydroxy-2H-1-benzopyran-2-one; Umbelliferone, suitable for fluorescence indicator, >=98.0% (HPLC); 142044-47-1
CAS 93-35-6
PubChem CID 5281426
ChEMBL ID CHEMBL51628
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Phenylpropanoids and poly
      • Class: Coumarins and derivatives
        • Subclass: Hydroxycoumarins
          • Direct Parent: 7-hydroxycoumarins

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 162.14 ALogp: 1.6
HBD: 1 HBA: 3
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 46.5 Aromatic Rings: 2
Heavy Atoms: 12 QED Weighted: 0.603

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.679 MDCK Permeability: 0.00001480
Pgp-inhibitor: 0.001 Pgp-substrate: 0.986
Human Intestinal Absorption (HIA): 0.007 20% Bioavailability (F20%): 0.991
30% Bioavailability (F30%): 0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.08 Plasma Protein Binding (PPB): 85.68%
Volume Distribution (VD): 0.603 Fu: 18.81%

ADMET: Metabolism

CYP1A2-inhibitor: 0.973 CYP1A2-substrate: 0.847
CYP2C19-inhibitor: 0.282 CYP2C19-substrate: 0.063
CYP2C9-inhibitor: 0.041 CYP2C9-substrate: 0.918
CYP2D6-inhibitor: 0.664 CYP2D6-substrate: 0.859
CYP3A4-inhibitor: 0.603 CYP3A4-substrate: 0.231

ADMET: Excretion

Clearance (CL): 13.575 Half-life (T1/2): 0.834

ADMET: Toxicity

hERG Blockers: 0.101 Human Hepatotoxicity (H-HT): 0.121
Drug-inuced Liver Injury (DILI): 0.723 AMES Toxicity: 0.047
Rat Oral Acute Toxicity: 0.378 Maximum Recommended Daily Dose: 0.191
Skin Sensitization: 0.428 Carcinogencity: 0.841
Eye Corrosion: 0.575 Eye Irritation: 0.99
Respiratory Toxicity: 0.17
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000025 0.571 D08SKH 0.379
ENC001561 0.556 D03UOT 0.333
ENC001539 0.522 D0S2BV 0.310
ENC001537 0.521 D0DJ1B 0.306
ENC002806 0.447 D0U5QK 0.306
ENC002764 0.431 D08ZEB 0.300
ENC004623 0.393 D04AIT 0.296
ENC001524 0.389 D0K8KX 0.288
ENC000078 0.379 D05CKR 0.281
ENC001576 0.375 D01CRB 0.278
*Note: the compound similarity was calculated by RDKIT.